Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.

about

Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.

Item

http://www.wikidata.org/entity/Q35990530

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@ast

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@en

type

Item

label

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@ast

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@en

prefLabel

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@ast

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@en

P1476

Changes in endocrine therapy: ...... ancer in postmenopausal women.

@en

P2093

Jean-Marc Nabholtz

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

Tamoxifen resistance in breast cancer: elucidating mechanisms.

A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases.

ARIMIDEX: a new oral, once-a-day aromatase inhibitor.

Cancer statistics, 2003.

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety upda

P304

457-465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/104990910402100612

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15612238

http://www.w3.org/2001/XMLSchema#string